drugset / Trial / NCT01982461

A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Hypercholesterolemia.

NCT01982461

RandomizedParallel-groupOpen-labelTreatment

Summary

The objective of this trial is to assess the efficacy of reducing plasma low-density lipoprotein(LDL) cholesterol and safety in two different brand drugs, Roty F.C. Tablets 10mg and Crestor 10mg F.C. Tablets in hypercholesterolemia population.

Timeline

Start
2013-11
Primary completion
2014-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule 10 mg

Indications